CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...

“First of all, it’s a platform technology that is capable of mapping both ... Two independent industry partners – AstraZeneca and Novartis – first conducted CRISPR-Cas9-based gene-editing of five well ...

By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.